Ready-to-go, complete automation solution for rapid nucleic acid extraction

Combine your SARS-CoV-2 assay with Tecan's high-throughput extraction automation solution

The DreamPrep NAP workstation featuring Zymo Research simplifies nucleic acid extraction workflows – today and in the future. Its optimized workflow for the Quick- DNA/RNA™ Viral MagBead kit was developed and verified in close collaboration with Zymo Research, and allows purification of up to 96 samples in less than two hours.

DreamPrep NAP COVID-19

Zymo Research recently evaluated the Quick-DNA/RNA Viral MagBead kit in a workflow to detect SARS-CoV-2 – the causative agent of COVID-19. Figure 1 shows qPCR results (data obtained by Zymo Research following the kit instructions in a manual workflow).

A significant inventory of the Quick-DNA/RNA Viral MagBead kit is available to address increasing global demand for optimal viral RNA extraction tools.

Figure 1: RT-qPCR amplification plots for a clinical sample and controls using a SARS-CoV-2 assay.
A sputum sample (200 µl stabilized in 2x 200 µl of DNA/RNA Shield™ transport and storage medium) was purified using the Quick-DNA/RNA Viral MagBead kit and eluted in 50 µl of DNase/RNase-free water. From this purified sample, 2.5 µl were analyzed using RT-qPCR to test for the presence of SARS-CoV-2 using human RNase P, 2019 nCoV_N1 (CV-1), 2019 nCoV_N2 (CV-2), and 2019 nCoV_N3 (CV-3) primer sets. Purified HeLa RNA and purified HeLa RNA spiked with a known target were used as negative and positive controls, respectively. RNase P crossed the Ct value before 35 cycles, indicating that the sample is of acceptable quality for the test.

Read more

Is your extraction procedure delivering inhibitor-free viral DNA/RNA for highly sensitive downstream detection?

Learn how DreamPrep NAP can process your increased workload using Zymo’s Quick-DNA/RNA Viral extraction chemistry.


Dr. Christopher Mason

Associate Professor at Weil Cornell Medical College, and his lab are in New York, at the epicenter of the COVID-19 outbreak in the US. He is examining the variation of SARS-CoV-2 RNA as it moves around the world. Learn more about the heroic efforts of his lab to meet throughput demands and the essential role of automation.

Watch the full interview
For research use only – not for use in diagnostic procedures.

Request more information

Contact us - Partnering NAP Corona